Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

JCO oncology practice·2026
Same author

Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic <i>HER2</i>-Mutant Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same author

Cochlear Implant Complications and Outcomes: National Trends of the MAUDE Database From 2016 to 2024.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Mental Health Risk Factors for Postoperative Pain in Head and Neck Free Flap Reconstruction Patients.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Reusing Blood Samples from a Hospital-based Cohort to Apixaban Plasma Concentrations.

medRxiv : the preprint server for health sciences·2026
Same author

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Jan 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Computational Framework for Structuring and Analyzing Clinical Trial Criteria for AI-Guided Fine-grained Matching.

Daniel R S Habib1, Ishan Mahajan2, Betina Evancha1

  • 1Vanderbilt University School of Medicine, Nashville, TN, USA.

Journal of Medical Systems
|November 22, 2025
PubMed
Summary

Artificial intelligence (AI) for clinical trial matching needs more than simple data. This study developed a framework to analyze complex trial criteria, improving AI accuracy and patient access.

Keywords:
Artificial intelligenceClinicalDecision support systemsEligibility determinationMedical informaticsNatural language processing

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

Area of Science:

  • Clinical Informatics
  • Artificial Intelligence in Healthcare
  • Clinical Trial Management

Background:

  • Current artificial intelligence (AI) solutions for clinical trial matching often use oversimplified criteria or limited structured data.
  • This limitation hinders the potential of AI to effectively automate and optimize patient recruitment for clinical trials.
  • Existing methods struggle with the inherent complexity and variability of clinical trial eligibility criteria.

Purpose of the Study:

  • To introduce a novel framework for structuring and analyzing eligibility criteria from real-world clinical trial protocols.
  • To inform the development of more granular and effective AI-driven clinical trial matching strategies.
  • To quantify the complexity and variability of clinical trial eligibility criteria.

Main Methods:

  • Eligibility criteria from three clinical trial protocols were systematically decomposed into individual variables.
  • Variables were evaluated based on data type, scope, and interdependencies.
  • A novel complexity formula, incorporating variable interdependence and Flesch-Kincaid reading grade level, was developed and applied.

Main Results:

  • Clinical trial protocols contained between 22 and 160 eligibility variables, with 4-22% exhibiting interdependence.
  • Reading grade levels for criteria ranged from sixth grade to first-year college, indicating significant accessibility variation.
  • Complexity scores varied substantially, with high cognitive and logical burdens observed in some protocols, often featuring recursive and hierarchical structures.

Conclusions:

  • Clinical trial eligibility criteria exhibit significant variability and structural complexity, posing challenges for current AI matching systems.
  • A standardized method for assessing trial complexity can enhance AI algorithm transparency, scalability, and interpretability.
  • Developing structured, computable frameworks is crucial for improving the equity and efficiency of clinical trial recruitment.